InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Chee Conley. Officer active across 1 company, notably Syros Pharmaceuticals, Inc.. Aggregated, 6 reports have been logged. Breakdown: 1 buy · 1 sell. Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Chee Conley is linked to Syros Pharmaceuticals, Inc. as President & CEO. There are 6 filings in total, and among the sampled recent filings the period runs from 2023-04-04 to 2024-11-20, with one buy and one sell indicated, while the most frequent transaction nature is Option exercise.